Real ChatGPT answer · index seedsyUqybXfAAwcompleteHealth and wellness · pharmacies and prescriptionscomparison
What is the current medical guidance on missed dose double up advice for once-weekly GLP-1 receptor agonists like semaglutide if three days have passed since the scheduled injection?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What is the current medical guidance on missed dose double up advice for once-weekly GLP-1 receptor agonists like semaglutide if three days have passed since the scheduled injection?
1 real search · 1 real-search pass
FDA prescribing information semaglutide Ozempic missed dose within 5 days Wegovy more than 2 days missed dose 2026Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 1 queries…
Searches and sources
ChatGPT1 real searches · gpt-6
FDA prescribing information semaglutide Ozempic missed dose within 5 days Wegovy more than 2 days missed dose 2026 Google ↗
- These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use WEGOVY® safely and effectively. See full prescribing information for WEGOVY.WEGOVY (semaglutide) injection, for subcutaneous useWEGOVY (semaglutide) tablets, for oral useInitial U.S. Approval: 2017 · dailymed.nlm.nih.gov
- DailyMed - These highlights do not include all the information needed to use WEGOVY® safely and effectively. See full prescribing information for WEGOVY. WEGOVY (semaglutide) injection, for subcutaneous use WEGOVY (semaglutide) tablets, for oral use Initial U.S. Approval: 2017 · dailymed.nlm.nih.gov